HUBUNGAN POLIFARMASI DAN POTENSI DRUG-DRUG INTERACTION (DDI) PADA PASIEN PENYAKIT JANTUNG KORONER (PJK) DI RUMAH SAKIT SWASTA BEKASI

Nofria Rizki Amalia Harahap; Ranti Amanda Putri

doi:10.33759/jrki.v7i2.627

Authors

Nofria Rizki Amalia Harahap Sekolah Tinggi Ilmu Kesehatan Mitra Keluarga
Ranti Amanda Putri Sekolah Tinggi Ilmu Kesehatan Mitra Keluarga

DOI:

https://doi.org/10.33759/jrki.v7i2.627

Keywords:

Coronary Heart Disease, Polypharmacy, Drug Interactions

Abstract

Patients with coronary heart disease are at high risk of experiencing medication interactions due to the practice of polypharmacy, which involves taking multiple medications. This can lead to negative treatment outcomes. This study aimed to examine the link between polypharmacy and the potential for drug interactions in patients with coronary heart disease. An observational study utilizing a cross-sectional design was carried out using consecutive sampling. The study included 105 patients. The potential for drug interactions was presented in a table based on each patient's medication profile. The relationship between polypharmacy and the potential for drug interactions was analyzed using the chi-square test. The findings revealed that the majority of patients were male (78.1%) and aged 55-64 years (50.48%). The most common potential drug interactions were clopidogrel with atorvastatin (17.54%), followed by atorvastatin-amlodipine (11.7%) and ticagrelor-acetylsalicylic acid (11.11%). The analysis of the relationship between the number of drugs (polypharmacy) and the number of potential drug interactions resulted in a significant value of 0.000 (<0.05) with an odds ratio of 18.5. This means that patients using polypharmacy are 18.5 times more likely to experience drug interactions compared to those using fewer medications.

Downloads

Download data is not yet available.

References

Alvitigala, B. Y., Gooneratne, L. V., Constantine, G. R., Wijesinghe, R. a. N. K., & Arawwawala, L. D. a. M. (2020). Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy. Pharmacology Research & Perspectives, 8(6). https://doi.org/10.1002/prp2.686

Arsyad, D. S., Hageman, S. H., Qalby, N., Ansariadi, Wahiduddin, Qanitha, A., Mappangara, I., Doevendans, P. A., Visseren, F. L., & Cramer, M. J. (2023). Very High Risk of Recurrent Cardiovascular Events in Indonesian Patients with Established Coronary Heart. Radcliffe Cardiology. https://www.japscjournal.com/articles/very-high-risk-recurrent-cardiovascular-events-indonesian-patients-established-coronary

Ashorobi, D., Ameer, M. A., & Fernandez, R. (2024, February 12). Thrombosis. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK538430/

Badan Penelitian dan Pengembangan Kesehatan. (2018). Laporan Nasional RISKESDAS 2018. Jakarta: Kemenkes RI.

BHF. (2023). Global Heart & Circulatory Diseases Factsheet. London: British Heart Foundation.

Brown, J. C., Gerhardt, T. E., & Kwon, E. (2023, January 23). Risk Factors for Coronary Artery Disease. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK554410/

Cofer, L. B., Barrett, T. J., & Berger, J. S. (2022). Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach. Arteriosclerosis Thrombosis and Vascular Biology, 42(10), 1207–1216. https://doi.org/10.1161/atvbaha.122.318020

Dasopang, E. S., Harahap, U., & Lindarto, D. (2015). Polipharmacy and Drug Interactions in Elderly Patients with Metabolic Diseases. Indonesian Journal of Clinical Pharmacy, 4(4), 235–241. https://doi.org/10.15416/ijcp.2015.4.4.235

Devarashetty, V., N, P., & R, M. (2020). Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. National Journal of Physiology Pharmacy and Pharmacology, 10(7), 1. https://doi.org/10.5455/njppp.2020.10.12389201926042020

Fadah, K., Hechanova, A., & Mukherjee, D. (2022). Epidemiology, Pathophysiology, and Management of Coronary Artery Disease in the Elderly. International Journal of Angiology, 31(04), 244–250. https://doi.org/10.1055/s-0042-1751234

Fried, T. R., O’Leary, J., Towle, V., Goldstein, M. K., Trentalange, M., & Martin, D. K. (2014). Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review. Journal of the American Geriatrics Society, 62(12), 2261–2272. https://doi.org/10.1111/jgs.13153

Hamadouk, R. M., Alshareif, E. M., Hamad, H. M., & Yousef, B. A. (2023). The Prevalence and Severity of Potential Drug–Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital. Drug Healthcare and Patient Safety, Volume 15, 149–157. https://doi.org/10.2147/dhps.s436458

Herron, G. C., & Bates, E. R. (2024). Review of the Ticagrelor Trials Evidence Base. Journal of the American Heart Association, 13(11). https://doi.org/10.1161/jaha.123.031606

Jia, L. Y., Cao, G. Y., Li, J., Gan, L., Li, J. X., Lan, X. Y., Meng, Z. Q., He, X., Zhang, C. F., Wang, C. Z., & Yuan, C. S. (2021). Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.698981

Kalash, A., Abdelrahman, A., Al-Zakwani, I., & Suleimani, Y. A. (2023). Potentially Harmful Drug–Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study. Drugs - Real World Outcomes, 10(3), 371–381. https://doi.org/10.1007/s40801-023-00373-3

Kemenkes RI. (2017). Rencana Aksi Kegiatan Pengendalian Penyakit Tidak Menular Revisi I Tahun 2017. Direktorat Pencegahan dan Pengendalian Penyakit Tidak Menular.

Kim, H. L. (2024). Sex differences in coronary atherogenesis: a narrative review. The Ewha Medical Journal, 47(2). https://doi.org/10.12771/emj.2024.e15

Lexicomp. (2024). Drug Interactions. United States: Wolters Kluwer Health Company.

Li, M., Wang, X., Li, X., Chen, H., Hu, Y., Zhang, X., Tang, X., Miao, Y., Tian, G., & Shang, H. (2019). Statins for the Primary Prevention of Coronary Heart Disease. BioMed Research International, 2019, 1–15. https://doi.org/10.1155/2019/4870350

McCarthy, C. P., Steg, G., & Bhatt, D. L. (2017). The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum. European Heart Journal, 38(47), 3488–3492. https://doi.org/10.1093/eurheartj/ehx531

Patel, R. B., & Secemsky, E. A. (2014). Clinical Features of Heart Failure and Acute Coronary Syndromes. Clinics in Laboratory Medicine, 34(1), 15–30. https://doi.org/10.1016/j.cll.2013.11.006

PERKI. (2018). Pedoman Tatalaksana Sindrom Koroner Akut Edisi IV. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.

PERKI. (2022). Panduan Prevensi Penyakit Kardiovaskular Aterosklerosis Edisi I. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.

Pinaire, J., Azé, J., Bringay, S., Cayla, G., & Landais, P. (2019). Hospital burden of coronary artery disease: Trends of myocardial infarction and/or percutaneous coronary interventions in France 2009–2014. PLoS ONE, 14(5), e0215649. https://doi.org/10.1371/journal.pone.0215649

Reyaan, I. B. M., Kuning, C., & Adnyana, I. K. (2021). Studi Potensi Interaksi Obat pada Resep Polifarmasi di Dua Apotek Kota Bandung. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 11(3), 145. https://doi.org/10.22146/jmpf.56931

Saleh, N. F. (2022). Karakteristik Penderita Penyakit Jantung Koroner di RSUD Dr. H. Chasan Boesoirie Ternate. KIERAHA MEDICAL JOURNAL, 4(2), 101–108. https://doi.org/10.33387/kmj.v4i2.5345

Shahjehan, R. D., & Bhutta, B. S. (2023, August 17). Coronary Artery Disease. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK564304/

Sheikh-Taha, M., & Asmar, M. (2021). Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatrics, 21(1). https://doi.org/10.1186/s12877-021-02183-0

Sulistian, W. D., Fuadi, M. R., Edijanto, S. P., & Yusuf, M. (2021). Effect of Dyslipidemia Therapy on Creatinine Kinase Activity Level in Patients with Heart Disease. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 27(2), 132–137. https://doi.org/10.24293/ijcpml.v27i2.1631

Vinci, P., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Di Girolamo, F. G., & Biolo, G. (2021). Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. International Journal of Molecular Sciences, 22(21), 11687. https://doi.org/10.3390/ijms222111687

Zhao, M., Liu, C. F., Feng, Y. F., & Chen, H. (2022). Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.946415